Parenterals

Feb 23, 2018
By Pharmaceutical Technology Editors
The company is voluntarily recalling three lots of Labetalol Hydrochloride Injection, USP, 100 mg/20 mL Vial and one lot of Labetalol Hydrochloride Injection, USP, Novaplus because of the potential of cracked glass at the rim of the vials.
Jan 05, 2018
By Pharmaceutical Technology Editors
FDA Commissioner Gottlieb expects that the saline and amino acid drug shortages from Puerto Rican manufacturing facilities will improve in the early part of 2018.
Jan 02, 2018
Pharmaceutical Technology
Glass and plastic are well established primary packaging materials for the pharmaceutical industry but they both have their advantages and disadvantages.
Jan 02, 2018
Pharmaceutical Technology
Measurements by a drone-based online pressure monitoring system help identify weak points in the filling line, enabling the process to be optimized.
Jan 02, 2018
Pharmaceutical Technology
The development of new packaging solutions that are fit for drugs of the future requires close collaboration between the pharmaceutical manufacturer and its packaging suppliers and machine vendors.
Dec 28, 2017
By Pharmaceutical Technology Editors
The recall was initiated due to a product complaint in which white particulate matter, identified as mold, was discovered in a flexible bag from one batch.
Dec 01, 2017
By Pharmaceutical Technology Editors
In a recently released statement, FDA Commissioner Scott Gottlieb warned of an amino acids supply shortage and gave an update on a saline supply shortage, both due to the impact of hurricanes on Puerto Rican manufacturing facilities.
Nov 28, 2017
By Pharmaceutical Technology Editors
The acquisition gives GE Healthcare access to a nanofiber-based platform purification technology that can offer improvements in biopharmaceutical productivity.
Oct 26, 2017
By Pharmaceutical Technology Editors
The biotechnology company’s drug for treating hives in adults has been granted an expanded indication by the European Commission to treat children and adolescents.
Oct 23, 2017
By Pharmaceutical Technology Editors
The $72-million investment, part of a larger $850-million investment into its US operations, will allow the drugmaker to replace an outdated insulin vial-filling line and to upgrade technology at its Indianapolis manufacturing plant.
native1_300x100
lorem ipsum